Literature DB >> 20534094

Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.

Sujay Khandpur1, Pankaj Chaturvedi, Uttam Kumar, Binod K Khaitan, Jyotish C Samantaray, Vinod K Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20534094     DOI： 10.1111/j.1365-4632.2010.04326.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

1.  Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.

Authors:  Zubeyde Akın Polat; Andreas Obwaller; Ayse Vural; Julia Walochnik
Journal:  Parasitol Res       Date:  2011-07-07       Impact factor: 2.289

2.  Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.

Authors:  D Mondal; M G Hasnain; M S Hossain; D Ghosh; P Ghosh; H Hossain; J Baker; R Nath; R Haque; G Matlashewski; S Hamano
Journal:  BMJ Open       Date:  2016-05-17       Impact factor: 2.692

3.  Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.

Authors:  V Ramesh; Ruchi Singh; Kumar Avishek; Aditya Verma; Deepak Kumar Deep; Sandeep Verma; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2015-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.